A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.
Wu, Y., Wang, F., Shen, C., Peng, W., Li, D., Zhao, C., Li, Z., Li, S., Bi, Y., Yang, Y., Gong, Y., Xiao, H., Fan, Z., Tan, S., Wu, G., Tan, W., Lu, X., Fan, C., Wang, Q., Liu, Y., Zhang, C., Qi, J., Gao, G.F., Gao, F., Liu, L.(2020) Science 368: 1274-1278
- PubMed: 32404477 
- DOI: 10.1126/science.abc2241
- Primary Citation of Related Structures:  
7BZ5 - PubMed Abstract: 
Neutralizing antibodies could potentially be used as antivirals against the coronavirus disease 2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal antibodies from a convalescent patient, all of which display neutralization abilities ...